Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development
4/25/2013 6:53:41 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ZURICH, April 25, 2013 /PRNewswire/ --
- Phase 2b clinical trial of CYT003 in allergic asthma on-going as planned
- Cytos' VLP platform is basis for a phase 1 clinical trial with an Anti-lgE Vaccine partnered with and conducted by Pfizer
Help employers find you! Check out all the jobs and post your resume.